S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
NYSE:A

Agilent Technologies (A) Stock Price, News & Analysis

$132.73
+0.29 (+0.22%)
(As of 04/19/2024 ET)
Today's Range
$132.15
$133.74
50-Day Range
$129.76
$149.36
52-Week Range
$96.80
$151.58
Volume
1.30 million shs
Average Volume
1.32 million shs
Market Capitalization
$38.90 billion
P/E Ratio
31.60
Dividend Yield
0.71%
Price Target
$141.29

Agilent Technologies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.59 Rating Score
Upside/​Downside
6.5% Upside
$141.29 Price Target
Short Interest
Healthy
1.35% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.75
Upright™ Environmental Score
News Sentiment
0.93mentions of Agilent Technologies in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$9.22 M Sold Last Quarter
Proj. Earnings Growth
10.53%
From $5.51 to $6.09 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.19 out of 5 stars

Computer And Technology Sector

149th out of 586 stocks

Analytical Instruments Industry

6th out of 26 stocks

A stock logo

About Agilent Technologies Stock (NYSE:A)

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

A Stock Price History

A Stock News Headlines

Agilent Technologies (NYSE:A) Shares Gap Down to $134.55
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Agilent Technologies (NYSE:A) PT Raised to $135.00 at Barclays
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Agilent Gains on Dilution System
See More Headlines
Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 1/24 Dividend
12/29/2023
Dividend Payable
1/24/2024
Last Earnings
2/27/2024
Ex-Dividend for 4/24 Dividend
4/01/2024
Today
4/21/2024
Dividend Payable
4/24/2024
Next Earnings (Estimated)
5/28/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
00846U10
Employees
18,100
Year Founded
1999

Price Target and Rating

Average Stock Price Target
$141.29
High Stock Price Target
$165.00
Low Stock Price Target
$90.00
Potential Upside/Downside
+6.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.59
Research Coverage
17 Analysts

Profitability

Net Income
$1.24 billion
Pretax Margin
19.78%

Debt

Sales & Book Value

Annual Sales
$6.83 billion
Cash Flow
$6.42 per share
Book Value
$19.98 per share

Miscellaneous

Free Float
N/A
Market Cap
$38.90 billion
Optionable
Optionable
Beta
1.11

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Should I Buy Agilent Technologies Stock? A Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.:

  • Agilent Technologies operates in three segments, including Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab, providing diversified revenue streams.
  • The company offers a wide range of analytical instruments and services, catering to the life sciences, diagnostics, and applied chemical markets globally.
  • Agilent Technologies focuses on innovation and research, staying competitive in the analytical instruments industry.
  • Recent developments in genomics, nucleic acid contract manufacturing, and biomolecular analysis present growth opportunities for the company.
  • With a current stock price that reflects positive market sentiment, investors may see potential for capital appreciation.

Cons

Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons:

  • Market volatility and economic uncertainties can impact the demand for analytical instruments, affecting Agilent's revenue.
  • Competition in the life sciences tools and services industry may pose challenges to Agilent's market share and pricing power.
  • Fluctuations in raw material prices could impact the company's production costs and margins.
  • Regulatory changes in the healthcare and life sciences sectors could affect Agilent's operations and profitability.
  • Global economic conditions and geopolitical factors may influence Agilent's international business operations and growth prospects.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, April 13, 2024. Please send any questions or comments about these Agilent Technologies pros and cons to contact@marketbeat.com.

A Stock Analysis - Frequently Asked Questions

Should I buy or sell Agilent Technologies stock right now?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 1 sell rating, 5 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" A shares.
View A analyst ratings
or view top-rated stocks.

What is Agilent Technologies' stock price target for 2024?

17 brokerages have issued 12-month target prices for Agilent Technologies' shares. Their A share price targets range from $90.00 to $165.00. On average, they anticipate the company's share price to reach $141.29 in the next year. This suggests a possible upside of 6.5% from the stock's current price.
View analysts price targets for A
or view top-rated stocks among Wall Street analysts.

How have A shares performed in 2024?

Agilent Technologies' stock was trading at $139.03 at the beginning of 2024. Since then, A shares have decreased by 4.5% and is now trading at $132.73.
View the best growth stocks for 2024 here
.

Are investors shorting Agilent Technologies?

Agilent Technologies saw a increase in short interest in March. As of March 31st, there was short interest totaling 3,950,000 shares, an increase of 10.3% from the March 15th total of 3,580,000 shares. Based on an average daily trading volume, of 1,590,000 shares, the days-to-cover ratio is currently 2.5 days. Currently, 1.4% of the shares of the stock are sold short.
View Agilent Technologies' Short Interest
.

When is Agilent Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 28th 2024.
View our A earnings forecast
.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) issued its quarterly earnings data on Tuesday, February, 27th. The medical research company reported $1.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.22 by $0.07. The medical research company had revenue of $1.66 billion for the quarter, compared to the consensus estimate of $1.59 billion. Agilent Technologies had a net margin of 18.35% and a trailing twelve-month return on equity of 27.09%. The business's quarterly revenue was down 5.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.37 EPS.
Read the conference call transcript
.

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies declared a quarterly dividend on Wednesday, February 21st. Stockholders of record on Tuesday, April 2nd will be given a dividend of $0.236 per share on Wednesday, April 24th. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date is Monday, April 1st.
Read our dividend analysis for A
.

Is Agilent Technologies a good dividend stock?

Agilent Technologies (NYSE:A) pays an annual dividend of $0.94 per share and currently has a dividend yield of 0.71%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 22.38%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 15.44% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

How will Agilent Technologies' stock buyback program work?

Agilent Technologies announced that its Board of Directors has approved a stock buyback program on Monday, January 9th 2023, which permits the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 4.4% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's leadership believes its stock is undervalued.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies issued an update on its second quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of 1.170-1.200 for the period, compared to the consensus earnings per share estimate of 1.270. The company issued revenue guidance of $1.6 billion-$1.6 billion, compared to the consensus revenue estimate of $1.6 billion.

What is Mike McMullen's approval rating as Agilent Technologies' CEO?

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by a variety of retail and institutional investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.24%), Allspring Global Investments Holdings LLC (0.11%), Vaughan Nelson Investment Management L.P. (0.07%), Gateway Investment Advisers LLC (0.04%), Grimes & Company Inc. (0.04%) and Perpetual Ltd (0.04%). Insiders that own company stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Henrik Ancher-Jensen, Jacob Thaysen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Philip Binns and Rodney Gonsalves.
View institutional ownership trends
.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Agilent Technologies have any subsidiaries?
The following companies are subsidiares of Agilent Technologies: ACEA BIO, ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Singapore (Global) Pte Ltd., Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako Denmark, Dako Denmark ApS, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.
Read More
This page (NYSE:A) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners